Key Takeaways Clorox's Cleaning business is gaining share as PURE and Scentiva launches beat expectations.Litter packaging, pricing and shelf-placement changes are slowing recovery despite distribution gains.ERP completion, shelf resets and pricing actions are expected to improve execution across the portfolio. The Clorox Company's (CLX - Free Report) Household segment remains its biggest source of stability, but recent commentary suggests that strength in one business alone may not be enough to drive broader growth. While the segment continues to benefit from solid demand in cleaning products and successful innovation, weakness in a few other categories is weighing on the company's overall momentum.
Management highlighted that the Cleaning business is the portfolio's standout performer. Product launches, including the Clorox PURE allergen platform and additions to the Scentiva lineup, are gaining shelf space, generating strong early consumer response and outperforming internal expectations. Despite an intensely promotional environment, the company has said that it continues to gain market share in cleaning, reinforcing the strength of its flagship brands.
However, the positive momentum in Household is being offset elsewhere. Fresh Step cat litter remains in the middle of a multi-year transformation, with new packaging, product claims and pricing architecture creating temporary disruption. Although distribution gains have met expectations, shelf placement issues and the complexity of converting shoppers to new products have slowed the recovery. Management also acknowledged that Food categories remain under pressure from elevated promotions and weaker-than-expected category demand.
Clorox believes execution rather than demand is the key variable. With the ERP rollout completed, management expects better service levels, stronger on-shelf execution and faster commercialization of innovation. Retail distribution points increased more than 5% in the third quarter of fiscal 2026, while additional shelf resets are expected through the fourth quarter. The company is also expanding revenue growth management initiatives, targeted pricing actions and brand investments to strengthen value perception.
The Household segment provides an important foundation, but Clorox's ability to sustain long-term growth will ultimately depend on whether improvements in Litter, Food and other businesses can match the momentum already visible in Cleaning.
CLX’s Price Performance, Valuation & EstimatesShares of the Zacks Rank #4 (Sell) company have lost 7.6% in the past three months against the industry’s growth of 5%.
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 15.66X compared with the industry’s average of 17.59X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 27.3%, while that of fiscal 2027 shows growth of 11.5%. The company’s EPS estimate for fiscal 2026 has been unchanged in the past 30 days.
Image Source: Zacks Investment Research
Stocks to Consider in the Consumer Staples SpaceUnited Natural Foods (UNFI - Free Report) is the leading distributor of natural, organic and specialty food and non-food products in the United States and Canada. The company currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for United Natural Foods’ current financial-year EPS indicates growth of a whopping 254.9% from the prior-year reported level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
Church & Dwight Co. Inc. (CHD - Free Report) develops, manufactures and markets a broad range of household, personal care and specialty products. The company currently has a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for CHD’s 2026 EPS indicates growth of 6.2% from the previous year’s reported figure. Church & Dwight delivered a trailing four-quarter average earnings surprise of 6.5%.
Krispy Kreme (DNUT - Free Report) operates as a branded retailer and wholesaler of doughnuts, coffee and other complementary beverages and treats and packaged sweets. The company currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Krispy Kreme’s current financial-year EPS indicates growth of 30% from the year-ago reported number. DNUT delivered a trailing four-quarter negative earnings surprise of 6.3%, on average.
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its fourth-quarter and fiscal year 2026 results on August 3, 2026. Timing for the announcement will be as follows:
1:15 p.m. PT / 4:15 p.m. ET: Press release and prepared management remarks posted on the company's website 2 p.m. PT / 5 p.m. ET: Live Q&A audio webcast for analysts with Chair and CEO Linda Rendle and Chief Financial Officer Luc Bellet Links to the webcast, press release and prepared remarks can be found at Clorox quarterly results.
About The Clorox Company
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and Purell® as well as international brands such as Chux®, Clorinda® and Poett®. Visit thecloroxcompany.com to learn more.
On the earnings front, Dick’s Sporting Goods, on May 27, reported mixed results for the first quarter. The company posted quarterly earnings of $2.90 per share, which missed the analyst consensus estimate of $2.93 per share. The company reported quarterly sales of $5.165 billion, which beat the analyst consensus estimate of $4.974 billion.
Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, said The Clorox Company (NYSE:CLX) has a 5% dividend yield.
As per the recent news, Clorox, on June 17, named Chris Hyder as COO.
Don’t forget to check out our premarket coverage here
Bill Baruch, founder and CIO of both Blue Line Capital, an investment advisor, and Blue Creek Capital Management, picked Nebius Group N.V. (NASDAQ:NBIS).
Nebius is expected to report earnings on Aug. 6. Wall Street expects a loss of 73 cents per share, compared with a loss of 38 cents a year earlier. Revenue is projected to rise to $576.67 million from $105.10 million a year ago.
Kevin Simpson, Capital Wealth Planning founder and CIO, recommended NVIDIA Corporation (NASDAQ:NVDA).
Nvidia shares closed higher on Friday after reports suggesting that China’s Alibaba, ByteDance and DeepSeek have received word that they might soon be approved to purchase the company’s H200 chips.
Price Action:
Dick’s Sporting shares rose 0.3% to close at $217.98 on Friday. Clorox shares gained 3.8% to settle at $96.56 during the session. Nebius Group shares gained 1.6% to close at $219.65 on Friday. Nvidia shares rose 4% to settle at $210.96 during the session. Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Analyst’s Disclosure: I/we have a beneficial long position in the shares of CLX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Clorox remains a defensive dividend play, appealing to long-term income-focused investors despite recent stock weakness. I see the premium valuation as a limiting factor, suggesting potential for price consolidation rather than outperformance. Turnaround potential exists if volatility returns, economic headwinds favor staples, or growth accelerates as analysts anticipate.
OAKLAND, Calif., June 17, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the company's strongest growth opportunities, advance portfolio optimization efforts and support faster execution across the enterprise to improve business performance.
Few consumer staples have been treated as roughly by the higher-for-longer rate regime as Clorox (NYSE:CLX | CLX Price Prediction). The stock sits down 18.6% over the past year, pushing the yield to a level rarely seen for a household-name aristocrat. With Goldman Sachs (NYSE:GS) projecting the Fed to cut another 50 basis points to 3-3.25% in 2026, income investors are starting to look back. The question I want to answer is simple: can Clorox actually afford this payout?
A 5.2% Yield Backed by a Multi-Decade Streak Metric Value Annual Dividend $4.96 Dividend Yield 5.21% Consecutive Years of Increases 51 years Most Recent Increase $1.22 to $1.24 quarterly (Q3 2025) Dividend King Status Yes Payout Ratios Are Stretched, but Cash Flow Still Covers Clorox paid roughly $600 million in dividends against $761 million in FY2025 free cash flow. Trailing EPS of $6.15 against the $4.96 dividend produces an earnings payout ratio in the low 80s, which is elevated for a staples name.
Metric TTM Value Assessment Earnings Payout Ratio ~81% Elevated FCF Payout Ratio ~79% Elevated Operating Cash Flow Coverage 1.64x Adequate The wrinkle: FY2026 adjusted EPS guidance of $5.45 to $5.65 implies the earnings payout climbs near 90% before the ERP transition normalizes. FCF is the better lens here, and it still works.
Thin Equity, but a $1.2 Billion Cash Cushion Metric Value Assessment EBITDA (TTM) $1.274B Stable EV/EBITDA 11.2x Reasonable Cash on Hand $1.187B Solid Buffer Shareholders’ Equity $92M Thin (buyback-driven) The negative book value is optical, the byproduct of decades of buybacks. The cash position, up 425% year-over-year, is the real story and gives management room to absorb GOJO integration costs.
Half a Century of Raises, Now Slowing Year Annual Dividend 2026 $4.96 2025 $4.88 2024 $4.84 2023 $4.72 2022 $4.64 The 5-year dividend CAGR works out to roughly 2.2%, modest but unbroken.
Rendle Stays Measured CEO Linda Rendle told investors on the Q3 FY26 call: “Looking ahead, we recognize there is more work to do in what continues to be a challenging consumer and cost environment.” That tone is measured and capital-allocation focused. Capital allocation language remains anchored to the dividend.
The Verdict: Safe, With a Watch on FY2026 Earnings Dividend Safety Rating: Safe. FCF covers the payout with room, the cash buffer is real, and the streak is intact. The dividend thesis holds together if FY2026 organic sales stabilize and ERP normalization plays out as guided. The setup deteriorates if the earnings payout pushes past 95% on further guidance cuts. For now, the yield is doing its job.
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Clorox Company (“Clorox” or the “Company”) (NYSE: CLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Clorox and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On April 30, 2026, Clorox reported its third quarter fiscal 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed that gross margin decreased 140 basis points to 43.2%, compared to 44.6% in the prior-year period. In addition, Clorox lowered its full-year fiscal 2026 gross margin outlook, stating that gross margin was now expected to decline 250 to 300 basis points, compared to the Company’s prior expectation at the low end of a 50 to 100 basis point decline range. During the Company’s earnings call, Clorox further disclosed that gross margin came in below expectations due to higher-than-expected supply chain costs and delayed cost savings as the Company prioritized ERP stabilization.
On this news, Clorox’s stock price fell $9.33 per share, or 9.67%, to close at $87.11 per share on May 1, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
As the market indexes hover near all-time highs, investors appear optimistic, as stocks tied to areas such as artificial intelligence (AI) continue moving higher.
Nonetheless, such moves may worry long-term investors. The Shiller price-to-earnings (P/E) ratio, which averages earnings over a 10-year period adjusted for inflation, is now at around 42. The only other time it reached that level was during the dot-com boom, and as many long-term investors know, that gave way to a dot-com bust.
That history has me concerned. Although I'm not giving up on the stock market, I'm making three moves that I think will protect me should the worst happen.
Image source: Getty Images.
1. Let winners keep winning Leaving my highfliers alone may seem counterintuitive. I own AMD (AMD +4.91%), whose P/E ratio is over 140 at recent prices, and Shopify (SHOP 1.99%), whose P/E ratio is pushing 100 even amid concerns that AI threatens the business models of many software companies.
However, I still believe in the long-term theses of these underlying businesses. With regard to AMD, the company's growth prospects appear to support investors' enthusiasm, as its revenue growth rate closely approximates the 35% annual target over the next three years. In Shopify's case, it has built a nearly comprehensive e-commerce ecosystem. Thus, it will probably take more than an AI application to disrupt that business.
Moreover, history shows that holding to such beliefs over the long term. Perhaps one of the better examples is Amazon (AMZN 1.24%). Although it's up by almost 279,000% since its 1997 IPO, it lost more than 90% of its value during the dot-com bust before its comeback, bringing massive returns that more than make up for any failed investments.
Although enduring those sell-offs can be difficult emotionally, history shows that it pays to keep the faith in a solid investment thesis.
2. Stay liquid Second, I'm keeping significant liquidity on hand. That includes cash and iShares Gold Trust (IAU +0.08%), a gold-tracking stock that I hold as an inflation hedge and can convert to cash quickly.
Here I'm following the example of Berkshire Hathaway (BRKA +0.76%) (BRKB +0.71%). As Warren Buffett was getting ready to retire as CEO, he built a record liquidity position now topping $397 billion, more than the company's current $329 billion in reported holdings.
Buffett spoke of the virtues of buying in down markets. In such times, holding a massive liquidity position may mean that Berkshire, now run by Greg Abel, is gearing up for such an opportunity.
Assuming a downturn occurs, investors will be able to buy bear market stocks at a significant discount. Ultimately, we have no way of knowing when the next bear market will arrive or how severe it will be. That doesn't mean one will find Amazon selling at a 90% discount again, but a sell-off should make more of the market's top businesses trade at attractive prices.
More importantly, investors should remember that every previous bear market eventually ended. That positions long-term investors to benefit because the bear market occurred, and investors should probably position themselves to reap such rewards.
3. Seek bargains, always Despite the high valuations, investors can find stocks to buy in this market. Many stocks don't move with the economy, so they can make great investments at the height of a bull market and could rise even as the overall market plunges.
For example, there's my contrarian take on Clorox (CLX 1.51%). I see it as a high-yield dividend stock with a cash return of around 5.6%, far above the 1.1% average for the S&P 500. It also has a history of annual payout increases, and its P/E ratio of 14 is less than half of the average 32 P/E ratio.
Today's Change
(
-1.51
%) $
-1.48
Current Price
$
96.82
Admittedly, no individual stock is risk-free, and Clorox -- whose revenue has grown at an annualized rate around 2% over the past decade -- is not for everyone. Nonetheless, it serves as a reminder that investors should always be on the lookout for a buying opportunity.
Investing in today's market environment The market is near record levels, and that leaves some investors wondering what to do. While history shows that bear markets happen eventually, we don't know how long the current bull market will continue.
However, an impending bear market is not a reason to give up on the stock market. As long as investors let winners win, hold some available cash, and always looks for opportunities, they can be in a position to win in the long term, no matter what happens next in the market.
LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Clorox Company (“Clorox” or “the Company”) (NYSE: CLX) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Clorox reported its Q3 2026 financial results on April 30, 2026. The Company revealed that its gross margin decreased for the quarter compared to the prior-year period. The Company also lowered its full-year gross margin outlook. The company further disclosed during its earnings call that its gross margin shortfalls were due to supply chain costs and delayed cost savings. Based on this news, shares of Clorox fell by more than 9.6% on May 1, 2026.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335 [email protected]
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will participate in a fireside chat at the dbAccess Global Consumer Conference on Wednesday, June 3, in Paris.
A live webcast of the presentation will begin at 12:00 p.m. CEST (6:00 a.m. ET and 3:00 a.m. PT) and can be accessed on the company's website. A replay of the webcast will be available following the event.
About The Clorox Company
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and Purell® as well as international brands such as Chux®, Clorinda® and Poett®. Visit thecloroxcompany.com to learn more.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Clorox Company ("Clorox" or the "Company") (NYSE: CLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Clorox and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On April 30, 2026, Clorox reported its third quarter fiscal 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed that gross margin decreased 140 basis points to 43.2%, compared to 44.6% in the prior-year period. In addition, Clorox lowered its full-year fiscal 2026 gross margin outlook, stating that gross margin was now expected to decline 250 to 300 basis points, compared to the Company's prior expectation at the low end of a 50 to 100 basis point decline range. During the Company's earnings call, Clorox further disclosed that gross margin came in below expectations due to higher-than-expected supply chain costs and delayed cost savings as the Company prioritized ERP stabilization.
On this news, Clorox's stock price fell $9.33 per share, or 9.67%, to close at $87.11 per share on May 1, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Clorox Company (“Clorox” or the “Company”) (NYSE: CLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Clorox and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On April 30, 2026, Clorox reported its third quarter fiscal 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed that gross margin decreased 140 basis points to 43.2%, compared to 44.6% in the prior-year period. In addition, Clorox lowered its full-year fiscal 2026 gross margin outlook, stating that gross margin was now expected to decline 250 to 300 basis points, compared to the Company’s prior expectation at the low end of a 50 to 100 basis point decline range. During the Company’s earnings call, Clorox further disclosed that gross margin came in below expectations due to higher-than-expected supply chain costs and delayed cost savings as the Company prioritized ERP stabilization.
On this news, Clorox’s stock price fell $9.33 per share, or 9.67%, to close at $87.11 per share on May 1, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
New collaboration brings a playful twist to everyday trash routines, turning a household chore into a moment of humor and personality.
, /PRNewswire/ -- Glad®, the nation's leading brand of trash bags and food wraps* is bringing Sesame Street's Oscar the Grouch to limited-edition Glad trash bag packaging, now available exclusively at Walmart. Featuring the iconic character who famously loves trash, the new packs add humor, personality, and a playful twist, bringing a bit of joy to an otherwise mundane task.
Glad® Features Sesame Street’s Oscar the Grouch in new Limited-Edition Packaging.
Glad® Features Sesame Street’s Oscar the Grouch in new Limited-Edition Packaging. Why Sesame Street's Oscar the Grouch?
Following Glad's December revival of its iconic "Don't Get Mad. Get Glad." campaign featuring Sesame Street's Oscar the Grouch in a remix of the classic "I Love Trash" song, the collaboration now evolves from screen to shelf. By bringing Sesame Street's Oscar the Grouch directly onto Glad packaging, the brand continues its playful messaging while reinforcing that trash doesn't have to feel like a chore.
"We're always looking for ways to bring a little more joy to everyday routines," said Ericka Santos, Associate Director of Marketing at Glad. "Bringing Sesame Street's Oscar the Grouch to our packaging is a fun way to turn a routine chore into something that can make people smile, while staying true to our 'Don't Get Mad. Get Glad.' campaign."
What's the Collaboration About?
This Walmart-exclusive launch introduces limited-edition Glad packaging featuring Sesame Street's Oscar the Grouch, blending nostalgia into the everyday trash aisle. By pairing Glad's trusted household essentials with one of pop culture's most lovable trash enthusiasts, the collaboration creates a lighthearted moment for families.
"Sesame Street has always found ways to bring humor and heart to everyday moments," said Gabriela Arenas, Senior Vice President, Global Licensing at Sesame Workshop, the global nonprofit behind Sesame Street. "Oscar is a natural fit when it comes to a playful and unique way to celebrate trash."
Beyond Walmart: There's More Where That Came From!
While Walmart marks the first phase of the rollout, the collaboration is set to expand to Target and Dollar General stores beginning in July. At Target, Glad will further build on the momentum through a back-to-school sweepstakes, extending the campaign into another key seasonal shopping moment.
Beyond delighting shoppers, the limited-edition packaging also provides retailers with fresh in-store merchandising opportunities, with incremental displays already secured across major retailers.
Wait, Haven't Glad and Sesame Street's Oscar the Grouch Teamed Up Before?
If this collaboration feels familiar, that's because it builds on Glad's December 2025 campaign, where Sesame Street's Oscar the Grouch was featured in the relaunch of "Don't Get Mad. Get Glad." through a Broadway-inspired musical number celebrating trash. The new packaging program marks the next chapter in that collaboration, bringing the same humor and personality directly into consumers' homes.
Where to Find It
Glad ForceFlex with Gain limited-edition Sesame Street's Oscar the Grouch packs are available now exclusively at Walmart, with Target and Dollar General launches beginning in July.
About Glad
The Glad Products Company, the nation's leading household waste solutions company, specializes in kitchen and outdoor trash bags as well as food protection products. By providing innovative and trusted solutions, Glad brings unquestioned dependability to an unpredictable world. Glad is a member of The Clorox Company (NYSE: CLX) family of brands. For more information, go to Glad.com. CLX-B.
About Sesame Workshop
Sesame Workshop is the global nonprofit behind Sesame Street and so much more. For over 50 years, we have worked at the intersection of education, media, and research, creating joyful experiences that enrich minds and expand hearts, all in service of empowering each generation to build a better world. Our beloved characters, iconic shows, outreach in communities, and more bring playful early learning to families in more than 190 countries and advance our mission to help children everywhere grow smarter, stronger, and kinder. Learn more at www.sesame.org and follow Sesame Workshop on Instagram, TikTok, Facebook, and X.
*based on Circana, U.S. multi‑outlet dollar sales data for Trash Disposal and Food Wraps, 52 weeks ending April 26, 2026
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Clorox Company ("Clorox" or the "Company") (NYSE: CLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Clorox and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On April 30, 2026, Clorox reported its third quarter fiscal 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed that gross margin decreased 140 basis points to 43.2%, compared to 44.6% in the prior-year period. In addition, Clorox lowered its full-year fiscal 2026 gross margin outlook, stating that gross margin was now expected to decline 250 to 300 basis points, compared to the Company's prior expectation at the low end of a 50 to 100 basis point decline range. During the Company's earnings call, Clorox further disclosed that gross margin came in below expectations due to higher-than-expected supply chain costs and delayed cost savings as the Company prioritized ERP stabilization.
On this news, Clorox's stock price fell $9.33 per share, or 9.67%, to close at $87.11 per share on May 1, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Are you seeking stability or value in the household goods market? Comparing Procter & Gamble (PG +0.86%) and Clorox (CLX 1.51%) reveals two distinct paths for conservative investors today.
Procter & Gamble is a global behemoth with a massive portfolio of diverse household brands, while Clorox focuses on specialized cleaning and wellness products with a smaller footprint. Both are defensive stalwarts, yet their scale and balance sheet health vary significantly.
The case for Procter & GambleProcter & Gamble operates through ten distinct categories, including grooming, health care, and beauty. Its products reach consumers in over 180 countries, making it one of the largest consumer staples companies by market cap. While its global reach is wide, the company depends heavily on Walmart for approximately 16% of its sales. Customer concentration like this adds a layer of risk to the business, as any change in shelf space or pricing terms could impact results.
In its 2025 fiscal year, ended June 30, revenue reached $84.3 billion, representing a slight growth of 0.3% compared to the prior year. Net income for the period was $15.7 billion, yielding a net margin of 19%. This margin, which measures the percentage of revenue remaining after all expenses are paid, indicates how much profit is generated from each dollar of sales.
As of the June 2025 balance sheet, the debt-to-equity ratio was 0.7x. This metric compares total debt to shareholder equity, indicating how much of the company is funded by lenders versus owners. The current ratio, which measures the ability to pay short-term debts with liquid assets, was 0.7x. Free cash flow for the year was $14 billion, representing cash from operations minus money spent on capital expenditures.
The case for CloroxThe Clorox Company maintains a portfolio focused on cleaning, wellness, and household convenience. Its brands, such as Pine-Sol, Glad, and Burt's Bees, are staples in many homes and professional settings. Like its larger peer, the company faces significant customer concentration, with Walmart accounting for nearly 27% of fiscal 2025 sales. Such heavy reliance on a single retailer can make the business vulnerable to changes in purchasing patterns or retail floor-space allocations.
During its 2025 fiscal year, which also ended June 30, revenue was $7.1 billion, reflecting a modest growth of about 0.2% over the previous year. Net income for the fiscal period reached $810.0 million, compared to just $280.0 million in the prior year. This performance led to a net margin of 11.4%, which measures how efficiently the firm turns revenue into profit after taxes and costs.
Based on its June 2025 financial report, the debt-to-equity ratio was 9.0x. This indicates a high level of debt relative to shareholder equity, which is a common point of analysis for capital-intensive companies. The current ratio stood at 0.8x, a metric that helps investors assess short-term liquidity and the ability to cover immediate bills. Free cash flow for the year was $761.0 million, calculated as operating cash flow minus expenditures on physical assets.
Risk profile comparisonProcter & Gamble faces intense competition from global rivals such as Unilever. These competitors often battle for shelf space and consumer loyalty through aggressive marketing and pricing. The company also deals with geopolitical instability and trade controls, which can disrupt global manufacturing networks. Furthermore, cyber-attacks or IT failures pose a constant threat to its complex international operations.
Clorox deals with heavy competition from both name brands and lower-priced private label products. Larger competitors such as Colgate-Palmolive may have more financial resources to capture market share. The company is also exposed to supply chain volatility, particularly regarding the cost of raw materials like resin and energy. Geopolitical conflicts and inflation also threaten to squeeze profitability if higher costs cannot be passed to consumers.
Valuation comparisonClorox currently trades at a lower P/S ratio relative to both its larger rival and its expected Forward P/E.
MetricThe Procter & GambleThe CloroxSector BenchmarkForward P/E20.8x17.4x25.5xP/S ratio4.0x1.6xSector benchmark uses the SPDR XLP sector ETF. Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Choosing to invest in Procter & Gamble or Clorox is a good move to add defensive stocks to a portfolio. However, neither is a high-growth company, so investors would be buying primarily for their dividend income.
From that perspective, Procter & Gamble offers a robust dividend yield of 2.9% as of May 28. Clorox provides a far higher dividend yield of 5.1%, which makes it appear to be the better buy. But there’s an important consideration here.
The ability to pay dividends is determined based on available free cash flow (FCF). Procter & Gamble generates robust FCF. In its latest fiscal quarter, ended March 31, the company produced adjusted FCF of $3.0 billion, an increase over the prior year’s $2.8 billion. Rising FCF is a good sign that Procter & Gamble can not only maintain its dividend, but afford to raise it as well.
Clorox generates much lower FCF, but it grew FCF to $761 million in fiscal year 2025 compared to $483 million in 2024. The company is also undertaking initiatives to reduce its expenditures and streamline operations, which point to the potential for further improvements in FCF.
But given Procter & Gamble‘s far greater FCF amount, it would be my choice to invest in over Clorox, even though the latter has the higher dividend yield.
Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO
, /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle will remain Chair and CEO while the search is conducted and until the new CEO is appointed. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition. The search will be comprehensive, led by an independent CEO search committee of the Board with the support of a leading executive search firm.
"Linda has been an exceptional CEO for Clorox, steering the company through a period of significant transformation and volatility," said Matthew J. Shattock, lead independent director of The Clorox Company Board of Directors. "She has helped make the company stronger, more agile and better positioned for the future. Linda has modernized our digital and operational foundation, sharpened the portfolio toward faster-growing health and hygiene categories, and accelerated innovation while continuing to invest in our brands, people and growth. While we are saddened by her decision, we are grateful that she will remain in place during the search and as an advisor for a period after the new CEO is appointed. We fully respect and support her personal decision and are confident that the process we are putting in place will result in a strong leader who is well positioned to lead Clorox into its next chapter of growth and value creation."
"Serving as CEO of Clorox for the past six years—and being part of this special company for more than two decades—has truly been the privilege of my career," said Rendle. "This was an incredibly difficult and deeply personal decision but after thoughtful reflection, I believe now is the right time to begin working toward a leadership transition so I can focus more fully on my health and family once a successor is appointed.
I remain fully committed to leading Clorox in the coming months through this transition and ensuring a smooth handoff to the company's next leader. I'm proud of what our team has accomplished during one of the most consequential periods in the company's history. Our experienced management team remains fully focused on strengthening execution, advancing innovation and delivering superior customer value as we continue to restore profitable growth and market share. While the operating environment remains challenging, I'm confident the actions we are executing today are positioning Clorox for long-term success."
Rendle posted a personal message regarding her decision on the company's website.
Rendle and Chief Financial Officer Luc Bellet will participate in a fireside chat at the dbAccess Global Consumer Conference on Wednesday, June 3, in Paris at 12pm CEST. The webcast can be accessed here.
About The Clorox Company
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and Purell® as well as international brands such as Chux®, Clorinda® and Poett®. Visit thecloroxcompany.com to learn more.
Clorox Healthcare launches two new innovative products designed to help close a critical compliance gap in daily disinfection: Clorox Healthcare Quat Alcohol Disinfecting Wipes, featuring a 1-minute contact time and 40% less alcohol*, and Clorox Healthcare HyperOxi Disinfecting Wipes a bleach-free sporicidal wipe powered by Quanticare Technology that is easy to use and gentle on surfaces.
Clorox Healthcare unveils an expanded healthcare portfolio designed to advance infection prevention with a quat alcohol-based daily disinfecting wipe and a bleach-free sporicidal disinfecting wipe. Wipes innovations help address emerging pathogen threats, burdens and support compliance in fast-paced healthcare environments where contact time protocols can be difficult to maintain. New products include Clorox Healthcare Quat Alcohol Disinfecting Wipes and Clorox Healthcare HyperOxi Disinfecting Wipes. , /PRNewswire/ -- Clorox Healthcare today announced two new innovative products designed to address critical challenges in infection prevention: Clorox Healthcare Quat Alcohol Disinfecting Wipes and Clorox Healthcare HyperOxi Disinfecting Wipes. These new wipes are designed to address critical needs in healthcare environments, helping improve workflow efficiency and compliance.
Clorox Healthcare Quat Alcohol Disinfecting Wipes
Clorox Healthcare HyperOxi Disinfecting Wipes New Clorox Healthcare Quat Alcohol Disinfecting Wipes Address Infection Prevention Challenges
The innovations come at a time of rapid change in infection prevention, as facilities face staffing pressures, escalating microbial threats—like C. auris—and increasing operational demands. Most existing quat alcohol wipes have contact times of two minutes or longer and contain high levels of alcohol, creating a compliance challenge: either staff cannot keep surfaces wet for the required contact time, or they must re-wipe surfaces to do so, resulting in added time and labor costs.
Clorox Healthcare Quat Alcohol Disinfecting Wipes are formulated with 40% less alcohol* to help keep surfaces wet for the full contact time and support compliant and efficient workflows. The patent-pending, triple-active formula gives healthcare facilities a new daily disinfecting option that delivers fast efficacy and built-in compliance.
Expanding Clorox Healthcare's Sporicidal Portfolio with a Bleach-Free Alternative
While Clorox has provided trusted, bleach-based solutions to healthcare and commercial facilities for more than 100 years, it is now introducing its first-ever bleach-free sporicidal wipes with Clorox Healthcare HyperOxi Disinfecting Wipes powered by Quanticare Technology. The non-bleach formula is designed to deliver broad-spectrum efficacy, eliminating C. difficile spores in 4 minutes and other pathogens—including TB, C. auris, and Norovirus—in 1 minute or less, while offering broad surface compatibility and a comfortable user experience.
Offering a non-bleach scent and minimal surface residue, the ready-to-use Clorox Healthcare HyperOxi Disinfecting Wipes provide sporicidal efficacy, without tradeoffs.
Expanded Portfolio Designed to Meet All Healthcare Disinfection Needs
Together, the introduction of Clorox Healthcare Quat Alcohol Disinfecting Wipes and Clorox Healthcare HyperOxi Disinfecting Wipes reflects Clorox Healthcare's commitment to developing cleaning and disinfecting solutions to meet the broad range of healthcare disinfection needs and solve real-world challenges. This expanded portfolio of ready-to-use wipes and sprays helps infection prevention and environmental services teams disinfect with greater confidence. Paired with Purell hand hygiene solutions, healthcare facilities gain access to a trusted portfolio of products, services and education across the infection prevention category to help improve patient safety.
Industry Leadership Perspective
"Infection prevention teams are under increasing pressure to do more with less and disinfection solutions must be designed for the realities of today's healthcare environments," said Alec Frisch, General Manager, CloroxPro. "With Clorox Healthcare Quat Alcohol Disinfecting Wipes and Clorox Healthcare HyperOxi Disinfecting Wipes, we're delivering innovations designed for real-world compliance—helping teams meet required contact times without added steps or slowdowns, while providing options that make sporicidal disinfection more comfortable for everyday use."
Availability
The new Clorox Healthcare Quat Alcohol Disinfecting Wipes and Clorox Healthcare HyperOxi Disinfecting Wipes will be available in small and large wipe sizes later this year through major healthcare distributors.
Pending full regulatory approvals. Contact your Clorox Healthcare representative for current availability information.
*vs. PDI Super-Sani Cloth Wipes
About Clorox Healthcare
Building on a century-long legacy in cleaning and disinfecting, Clorox Healthcare continues to advance infection prevention by offering a wide range of innovative products to help stop the spread of infection in healthcare facilities. Clorox Healthcare is committed to delivering trusted solutions that support the evolving needs of the healthcare community. For more information, visit www.CloroxHealthcare.com and follow CloroxPro on LinkedIn.
About Clorox Purell
Clorox Purell, formerly GOJO, is the leading global producer of skin health and hygiene solutions. As the inventors of PURELL Hand Sanitizer, Clorox Purell is committed to bringing innovative hygiene products, smart dispensing solutions and compliance-building programs that help improve the well-being of patients and healthcare workers. Its scale and reach expanded in 2026, when the enterprise joined The Clorox Company (NYSE: CLX). Clorox Purell is headquartered in Akron, Ohio and manufactures products in Northeast Ohio. For more information, visit www.gojo.com and follow Clorox Purell on LinkedIn.
About The Clorox Company
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita, Burt's Bees, Clorox, Fresh Step, Glad, Hidden Valley, Kingsford, Liquid-Plumr, Pine-Sol and now Purell as well as international brands such as Chux, Clorinda and Poett. Visit thecloroxcompany.com to learn more.
Clorox managed to keep its sales flat YoY and improve its EPS slightly, despite contracting gross margins, due to elevated energy prices. Based on a dividend discount model, assuming 2% growth in perpetuity and a 7.7% required rate of return, the upside from the current price levels seems to be limited. For these reasons, I upgrade CLX to hold.
